Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Roberto M, Barchiesi G, Resuli B, Verrico M, Speranza I, Cristofani L, Pediconi F, Tomao F, Botticelli A, Santini D. Roberto M, et al. Among authors: verrico m. Cancers (Basel). 2024 Jan 31;16(3):596. doi: 10.3390/cancers16030596. Cancers (Basel). 2024. PMID: 38339347 Free PMC article. Review.
Fertility and reproduction in breast cancer patients.
Tomao F, Verrico M, Tomao S. Tomao F, et al. Among authors: verrico m. Breast Cancer Res Treat. 2020 Jul;182(1):245-246. doi: 10.1007/s10549-020-05676-5. Epub 2020 May 20. Breast Cancer Res Treat. 2020. PMID: 32436144 No abstract available.
Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy.
Rossi L, Verrico M, Tomao S, Ricci F, Fontana A, Spinelli GP, Colonna M, Vici P, Tomao F. Rossi L, et al. Among authors: verrico m. Cancer Chemother Pharmacol. 2020 Jan;85(1):105-111. doi: 10.1007/s00280-019-03981-5. Epub 2019 Nov 21. Cancer Chemother Pharmacol. 2020. PMID: 31754747
Bevacizumab in ovarian cancer: A critical review of phase III studies.
Rossi L, Verrico M, Zaccarelli E, Papa A, Colonna M, Strudel M, Vici P, Bianco V, Tomao F. Rossi L, et al. Among authors: verrico m. Oncotarget. 2017 Feb 14;8(7):12389-12405. doi: 10.18632/oncotarget.13310. Oncotarget. 2017. PMID: 27852039 Free PMC article. Review.
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study.
Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S. Rossi L, et al. Among authors: verrico m. Ther Clin Risk Manag. 2013;9:457-62. doi: 10.2147/TCRM.S48387. Epub 2013 Nov 11. Ther Clin Risk Manag. 2013. PMID: 24255599 Free PMC article.
45 results